MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) — Orlando, Florida

MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2)?

MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) conducted?

MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) has 2 clinical trials on record. Their work covers Breast Cancer, HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.

Is MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) accredited by Crixeo Health?

MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando(2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.